Research ArticleHuman Apolipoprotein E Genotype Differentially Affects Olfactory Behavior and Sensory Physiology in Mice
Introduction
Apolipoprotein E (ApoE) is the primary carrier of cholesterol within the brain, and ApoE genotype is an important determinant of an individual’s risk for developing Alzheimer’s disease (AD) (Corder et al., 1993, Farrer et al., 1997, Bu, 2009, Liu et al., 2013). Three alleles of ApoE occur in humans: ε2 (cys112, cys158; ∼6% of the ApoE alleles in the population), ε3 (cys112, arg158; the most abundant allele at ∼80%), and ε4 (arg112, arg158; ∼14%) (Mahley, 1988, Mahley and Rall, 2000). ApoE4, in a dose-dependent manner, is the single most important genetic risk-factor for AD (Corder et al., 1993, Farrer et al., 1997, Bu, 2009, Liu et al., 2013). ApoE3 is viewed as the neutral allele in terms of neurodegenerative risk (Corder et al., 1993, Mahley and Rall, 2000, Liu et al., 2013) (and most closely resembles murine ApoE (Raffai et al., 2001)). ApoE2 is associated with a lower risk of AD-related neurodegeneration (Corder et al., 1994, Liu et al., 2013), delayed age of onset of AD, and a greater likelihood of survival to advanced age compared to the ApoE3 and ApoE4 alleles [reviewed in (Suri et al., 2013)]. In addition to AD, there is increasing evidence that ApoE is involved in several other disorders, with ApoE4 often exerting a deleterious and ApoE2 a protective effect; while not all studies have found a difference between ApoE2 and ApoE3 carriers [reviewed in (Suri et al., 2013)], both ApoE4 and ApoE2 appear to be associated with hemorrhagic and ischemic cerebrovascular disease [reviewed in (Liu et al., 2013, Suri et al., 2013, Lopez et al., 2014)], with a high risk of argyrophilic grain disease and frontotemporal dementia [reviewed in (Suri et al., 2013)]. ApoE2 also appears to confer an increased incidence and severity of posttraumatic stress disorder (PTSD) (Freeman et al., 2005, Kim et al., 2013, Johnson et al., 2015). While the effects of ApoE4 have been extensively studied, the inconsistencies among a small number of studies regarding the effect of ApoE2 may in part be due to challenges related to its low frequency allele.
While ApoE genotype may affect a myriad of neural circuits and functions, the olfactory system and olfactory perception appear to be a unique and early biomarker of ApoE genotype. In humans, ApoE4 carriers show early emergence of olfactory dysfunction (Price et al., 1991, Bacon et al., 1998, Mesholam et al., 1998, Murphy et al., 1998, Graves et al., 1999, Gilbert and Murphy, 2004, Josefsson et al., 2017, Peng et al., 2017), show impaired odor identification (Murphy et al., 1998, Olofsson et al., 2010, Olofsson et al., 2016), and modified olfactory related evoked potentials (Kowalewski and Murphy, 2012, Morgan and Murphy, 2012) prior to other forms of cognitive impairment, including AD impairment associated with amyloid β and tau pathology. In mice, ApoE4 impairs short-term odor memory and induces olfactory system hyperexcitability including in the olfactory bulb (OB) and piriform cortex (PCX) (Peng et al., 2017) as well as the lateral entorhinal cortex (Nuriel et al., 2017) The olfactory system is suitable for assessing links between cell biology, circuit function and behavior given its relatively simple circuitry and the availability of reliable, robust behavioral assays in both humans and non-human animals. ApoE is important for neuroregeneration of the rodent olfactory system (Nathan et al., 2005), and ApoE knock-out mice show impaired olfactory detection (Nathan et al., 2004). This olfactory dysfunction is associated with neurophysiological (Mesholam et al., 1998, Corby et al., 2012, Kowalewski and Murphy, 2012, Peng et al., 2017), structural (Tanaka et al., 1998, Hashimoto et al., 2001) and cellular changes (Tsuboi et al., 2003, Nathan et al., 2005, Hussain et al., 2013) in olfactory regions of the brain. Understanding how ApoE isoforms may influence olfactory system function and perception would provide important insights into ApoE4 as a major risk factor for olfactory and cognitive decline.
Here, we directly compared olfactory behavior and olfactory system physiology across all three ApoE genotypes in mice that are homozygous for human ApoE2, ApoE3, or ApoE4. We hypothesized a genotype-dependent gradient in odor habituation and olfactory system excitability, such that, for example, ApoE4 mice would display hyper-excitability and impaired behavioral habituation, and ApoE2 mice hypo-excitability and increased behavioral habituation, relative to ApoE3 mice. The results were in line with our hypotheses and they extend previous work (Peng et al., 2017).
Section snippets
Study approval
All animal procedures were performed in accordance with the Nathan S. Kline Institute (NKI) for Psychiatric Research Institutional Animal Care Committee’s approval.
Mice
Mice used in this experiment were homozygous for human ApoE2, ApoE3, and ApoE4 genes on a C57BL/6 background which are from long-standing colonies at NKI. These targeted-replacement mice express human ApoE under the control of the endogenous murine promoter (Sullivan et al., 1997), which allows for the expression of human ApoE at
Olfactory behavior
Independent of age or genotype, mice readily investigated novel odors presented to their homecage, suggesting no difference in behavioral odor responsiveness. As shown in Fig. 1, there was no age (F(1,34) = 0.001, p = 0.97) or genotype (F(2,34) = 1.3, p = 0.3) difference in the amount of time spent investigating the initial presentation of a novel odor.
In contrast, odor habituation was significantly affected by genotype (Fig. 2). For habituation, the analysis strategy was informed by prior
Discussion
Despite olfaction emerging as a system of importance to study the behavioral and physiological effects of ApoE, research remains limited. The present results demonstrate that while the initial tendency of mice to investigate novel odors is unaffected by ApoE genotype, odor habituation is impaired in E4 relative to E2 mice, with E3 mice presenting an intermediate functional level. Memory impairment in this simple task emerges in E4 mice by 6 months, as previously reported (Peng et al., 2017).
Acknowledgments
We thank Dr. Monika Pawlik for her expert assistance with our mouse colonies. This work was supported by the NIH (P01 AG017617 to EL and PMM, and R01 AG057517 to EL, PMM, and DAW; KP was additionally supported by an NIH postdoctoral research training grant T32-AG052909). JKO was supported by a Pro Futura Scientia VII fellowship and research grants from the Marianne and Marcus Wallenberg Foundation (MMW 2014:0178) and the Swedish Foundation for the Humanities and Social Sciences (M14–0375:1).
References (57)
- et al.
Abnormal event-related potentials in young and middle-aged adults with the ApoE epsilon4 allele
Int J Psychophysiol
(2012) - et al.
Combining early markers strongly predicts conversion from mild cognitive impairment to Alzheimer's disease
Biol Psychiatry
(2008) - et al.
Emergence of a seizure phenotype in aged apolipoprotein epsilon 4 targeted replacement mice
Brain Res
(2012) - et al.
Olfactory ERPs in an odor/visual congruency task differentiate ApoE epsilon4 carriers from non-carriers
Brain Res
(2012) - et al.
Apolipoprotein e sets the stage: response to injury triggers neuropathology
Neuron
(2012) - et al.
Olfactory function in apoE knockout mice
Behav Brain Res
(2004) - et al.
Delayed olfactory nerve regeneration in ApoE-deficient mice
Brain Res
(2005) - et al.
Odor identification impairment in carriers of ApoE-4 is independent of clinical dementia
Neurobiol Aging
(2010) - et al.
Long-term episodic memory decline is associated with olfactory deficits only in carriers of ApoE-4
Neuropsychologia
(2016) - et al.
Apolipoprotein E4 causes early olfactory network abnormalities and short-term olfactory memory impairments
Neuroscience
(2017)
The distribution of tangles, plaques and related immunohistochemical markers in healthy aging and Alzheimers-disease
Neurobiol Aging
APOE-related biomarker profiles in non-pathological aging and early phases of Alzheimer's disease
Neurosci Biobehav Rev
Targeted replacement of the mouse apolipoprotein E gene with the common human APOE3 allele enhances diet-induced hypercholesterolemia and atherosclerosis
J Biol Chem
Marked regional differences of brain human apolipoprotein E expression in targeted replacement mice
Neuroscience
Imbalance between GABAergic and Glutamatergic transmission impairs adult neurogenesis in an animal model of Alzheimer's disease
Cell Stem Cell
The forgotten APOE allele: a review of the evidence and suggested mechanisms for the protective effect of APOE varepsilon2
Neurosci Biobehav Rev
Apolipoprotein E in Alzheimer's disease and other neurological disorders
Lancet Neurol
Inhibitory interneuron deficit links altered network activity and cognitive dysfunction in Alzheimer model
Cell
Cortical processing of odor objects
Neuron
Early hyperactivity in lateral entorhinal cortex is associated with elevated levels of AbetaPP metabolites in the Tg2576 mouse model of Alzheimer's disease
Exp Neurol
Atrophy rates in asymptomatic amyloidosis: implications for Alzheimer prevention trials
PLoS One
Very early changes in olfactory functioning due to Alzheimer's disease and the role of Apolipoprotein E in olfaction
Ann N Y Acad Sci
Apolipoprotein E and its receptors in Alzheimer's disease: pathways, pathogenesis and therapy
Nat Rev Neurosci
Gene dose of apolipoprotein E type 4 allele and the risk of Alzheimer's disease in late onset families
Science
Protective effect of apolipoprotein E type 2 allele for late onset Alzheimer's disease
Nat Genet
ApoE-directed therapeutics rapidly clear beta-amyloid and reverse deficits in AD mouse models
Science
Olfactory deficits in patients with mild cognitive impairment predict Alzheimer's disease at follow-up
Am J Psychiatry
Effects of age, sex, and ethnicity on the association between apolipoprotein E genotype and Alzheimer disease. A meta-analysis. APOE and Alzheimer Disease Meta Analysis Consortium
JAMA
Cited by (14)
GABA<inf>A</inf> receptor agonist muscimol rescues inhibitory microcircuit defects in the olfactory bulb and improves olfactory function in APP/PS1 transgenic mice
2021, Neurobiology of AgingCitation Excerpt :Our findings provide promising clinical indications for preventing or treating AD. Neuronal and network hyperactivity in the OB is associated with olfactory dysfunction in the early stages of AD in transgenic mouse models (East et al., 2018; Li et al., 2019; Wesson et al., 2011; Xu et al., 2015). In this study, we found that the responsiveness of MCs is reduced due to the dramatic enhancement of background noise indicating an increase in the basal firing activity.
Sleep, neuronal hyperexcitability, inflammation and neurodegeneration: Does early chronic short sleep trigger and is it the key to overcoming Alzheimer's disease?
2021, Neuroscience and Biobehavioral ReviewsCitation Excerpt :Alterations in the strength of this coupling process by AD proteinopathies have resulted in synaptic impairments and cognitive deficits in several animal models of AD (Ahnaou et al., 2017, 2019, 2020; Goutagny et al., 2013; Iaccarino et al., 2016). Hyperexcitability of neural networks has been observed in the olfactory system of patients with AD (Karunanayaka et al., 2017; Lu et al., 2019a,b) and mouse models of AD (East et al., 2018; Xu et al., 2015a,b). Hyperexcitability of the olfactory system, including OB and piriform cortex, has resulted in impaired short-term odor memory and odor habituation (East et al., 2018; Peng et al., 2017; Wesson et al., 2011; Xu et al., 2015a,b).
Older, non-demented apolipoprotein ε<inf>4</inf> carrier males show hyperactivation and structural differences in odor memory regions: a blood-oxygen-level-dependent and structural magnetic resonance imaging study
2020, Neurobiology of AgingCitation Excerpt :Furthermore, excessive hyperactivation over time can lead to excitotoxicity and ultimately result in synapse degeneration and death (Mattson and Chan, 2003; Poirier et al., 1993; Woodard et al., 2010; Yanker, 1996) and has been suggested as one mechanism contributing to olfactory dysfunction in AD (Jacobson et al., 2019; Murphy, 2019). Interestingly, ApoE ε4 carrier mice show hyperactivation in olfactory areas that has been associated with olfactory deficits, suggesting that subtle, early olfactory deficits may presage future abnormalities in olfactory circuitry, and further supporting the hypothesis that hyperactivation is associated with olfactory dysfunction (East et al., 2018; Peng et al., 2017). This hyperactivation has been suggested to precede clinical symptoms in the AD pathological timeline (Gregory et al., 2017; Murphy, 2019).
3.34 - Function of the Olfactory Cortex
2020, The Senses: A Comprehensive Reference: Volume 1-7, Second EditionAmelioration of Cognitive and Olfactory System Deficits in APOE4 Transgenic Mice with DHA Treatment
2023, Molecular NeurobiologyOlfactory Evaluation in Alzheimer’s Disease Model Mice
2022, Brain Sciences